AI Maps Clinical Endpoints in Pompe Disease Using Real-World Data

Key facts

• Volv Global conducted a machine learning study on Pompe disease.
• The study analyzed US claims data from 3,549 patients.
• It tracked clinician-defined endpoints and discovered novel disease features.
• This is the largest machine learning study of Pompe disease to date.

Pompe disease is a rare genetic disorder that causes progressive muscle weakness. Identifying and tracking clinical endpoints is crucial for understanding disease progression and evaluating treatment efficacy. This study leverages machine learning and real-world data to advance these efforts.